Compare XNCR & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XNCR | HAFC |
|---|---|---|
| Founded | 1997 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 821.2M |
| IPO Year | 2013 | 2000 |
| Metric | XNCR | HAFC |
|---|---|---|
| Price | $12.36 | $30.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | $22.33 | ★ $32.17 |
| AVG Volume (30 Days) | ★ 701.9K | 225.7K |
| Earning Date | 05-08-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | ★ 65.36 | 22.44 |
| EPS | N/A | ★ 2.51 |
| Revenue | $125,576,000.00 | ★ $270,165,000.00 |
| Revenue This Year | N/A | $18.65 |
| Revenue Next Year | $4.80 | $7.28 |
| P/E Ratio | ★ N/A | $12.10 |
| Revenue Growth | 13.65 | ★ 15.28 |
| 52 Week Low | $6.92 | $21.84 |
| 52 Week High | $18.69 | $31.33 |
| Indicator | XNCR | HAFC |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | 62.84 |
| Support Level | $12.19 | $26.13 |
| Resistance Level | $13.10 | $31.33 |
| Average True Range (ATR) | 0.79 | 0.76 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 32.77 | 72.75 |
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.